FibroGen
FGEN
FGEN
192 hedge funds and large institutions have $4.05B invested in FibroGen in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 78 increasing their positions, 57 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
1% less funds holding
Funds holding: 193 → 192 (-1)
5% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 22
6% less call options, than puts
Call options by funds: $32.4M | Put options by funds: $34.4M
Holders
192
Holding in Top 10
4
Calls
$32.4M
Puts
$34.4M
Top Buyers
| 1 | +$628M | |
| 2 | +$25.7M | |
| 3 | +$24.3M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$23M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$20M |
Top Sellers
| 1 | -$37.8M | |
| 2 | -$15.4M | |
| 3 | -$13M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$12.4M |
| 5 |
Two Sigma Investments
New York
|
-$11.3M |